Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AQUESTIVE-THERAPEUTICS-IN-45049850/news/Aquestive-Therapeutics-Doses-First-Patient-in-Phase-3-Pivotal-Clinical-Study-Evaluating-Pharmacokine-45504105/?utm_source=whatsapp&utm_medium=social&utm_campaign=share